Can CBD Counter Binge-Eating?
Findings suggest that CBD may have therapeutic potential to reduce binge eating and the development of obesity, according to a paper published by Addiction Biology.
This category needs to be renamed to be meaningful than “Miscellaneous” but it will do for now. Basically it’s intended for news, research, legal actions and other information about medical marijuana for the general, nonexpert audience: patients, jouralists, the curious, etc.
GW Opposed Blumenauer-McClintock Amendment
On June 19 the House of Representatives voted to add the Blumenauer-McClintock Amendment —which would prevent the Department of Justice from enforcing federal law in states that have legalized adult-use marijuana—to an appropriations bill.
Add MJ Journals: ‘Medical Cannabis and Cannabinoids’
“Medical Cannabis and Cannabinoids” is a peer-reviewed journal offering an international forum to present and discuss recent advances in the rapidly developing field of medical cannabis and cannabinoids.
JAMA op-ed: ‘Educating Physicians About MJ’
Marijuana use is prevalent both in states where it is legal to some degree and in states where it is not. However, evidence suggests that many physicians may be unprepared for this reality.
Can Medical Marijuana Help with Dementia?
There’s no official endorsement of medical cannabis for dementia, but with or without scientific data, more and more people are willing to investigate cannabis to treat their loved ones.
Cannabidiol Adverse Effects and Toxicity.
Current Neuropharmacology, 3 June 2019
—
BACKGROUND: Currently, there is great interest in the potential medical use of cannabidiol (CBD), a non-intoxicating cannabinoid. Productive pharmacological research on CBD occurred in the 1970s and intensified recently with many discoveries about the endocannabinoid system. M…
Humboldt Humbled by Legalization
Although it’s entitled “How Legalization Changed Humboldt County Marijuana,” Emily Witt’s article in the New Yorker is not about new plant varieties but about new social realities.
You Must Remember This (Re: Mushrooms)
Eating mushrooms may reduce the risk of cognitive impairment, according to a study published in the Journal of Alzheimer’s Disease.
Epidiolex Weighs in at Schedule V
EPIDIOLEX®, a cannabidiol oral solution has been transferred to Schedule V, the lowest restriction classification, by the U.S. Drug Enforcement Administration. But CBD remains on Schedule I, due to its supposed abuse liability.
Russo’s Grand Unified Theory
Dr. Ethan Russo’s research on the Grand Unified Theory (GUT) that discusses how cannabis-based treatment and nutritional approaches can address five conditions that are difficult to treat with conventional medicine.
Meiri Publishes in Nature
In this seminal study, Dr. Dedi Meiri and his team from Israel enhance our knowledge of the content, effect, and variability of cannabinoids across 36 individual cannabis cultivars.
Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.
Canadian Journal of Veterinary Research, July 2018
—
The purpose of this study was to determine the pharmacokinetics of cannabidiol (CBD) in healthy dogs. Thirty, healthy research dogs were assigned to receive 1 of 3 formulations (oral microencapsulated oil beads, oral CBD-infused oil, or CBD-infused transdermal cream), at a dos…